Artificial Intelligence (AI) is at the heart of the latest global transformation, not least within the biopharmaceutical industry. AI is already rapidly redefining how we discover and design biologics ...
As AI agents code alongside humans, API platforms and DevRel must redesign for machine-first consumption.